Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 42,697 | 48,148 | 34,658 | 11,255 | 727 |
| Gross Profit | 42,697 | 48,148 | 34,658 | 11,255 | 727 |
| Operating Expenses | 24,101 | 26,138 | 23,712 | 22,424 | 16,647 |
| Operating Income | 18,596 | 22,011 | 10,946 | -11,169 | -15,920 |
| Other Income | 1,740 | 1,886 | 1,091 | 410 | 314 |
| Pre-tax Income | 20,336 | 23,897 | 12,037 | -10,759 | -15,606 |
| Net Income Continuous | 20,336 | 23,897 | 12,037 | -10,761 | -15,606 |
| Net Income | $20,336 | $23,897 | $12,037 | $-10,761 | $-15,606 |
| EPS Basic Total Ops | 0.21 | 0.25 | 0.13 | -0.11 | -0.18 |
| EPS Basic Continuous Ops | 0.21 | 0.25 | 0.13 | -0.12 | -0.18 |
| EPS Diluted Total Ops | 0.21 | 0.24 | 0.13 | -0.11 | -0.18 |
| EPS Diluted Continuous Ops | 0.21 | 0.24 | 0.13 | -0.12 | -0.18 |
| EBITDA(a) | $19,951 | $23,674 | $11,967 | $-10,140 | $-14,507 |